AI Engines For more Details: Perplexity Kagi Labs You
Parkinson's Disease Management: Entacapone is primarily used as an adjunctive treatment for Parkinson's disease. It works by inhibiting the enzyme catechol-O-methyltransferase (COMT), which breaks down levodopa, allowing levodopa to remain active in the brain for a longer duration. This can help reduce the fluctuations in motor function that are often seen in Parkinson's disease patients taking levodopa/carbidopa therapy alone.
Reduction of Motor Fluctuations: Parkinson's disease is characterized by motor fluctuations, including "on-off" periods and dyskinesias (abnormal involuntary movements), which can occur as the effects of levodopa wear off between doses. Entacapone helps to smooth out these fluctuations by prolonging the duration of levodopa's therapeutic effect, thereby reducing the frequency and severity of motor fluctuations.
Improved Symptom Control: By enhancing the availability of levodopa in the brain, entacapone can lead to better control of Parkinson's disease symptoms such as tremor, rigidity, bradykinesia (slowness of movement), and postural instability.
Dosage and Administration: Entacapone is typically taken orally in combination with levodopa and carbidopa. The dosage and frequency of administration vary depending on the individual patient's needs and response to treatment. It is usually taken with each dose of levodopa/carbidopa, but the exact timing and dosage should be determined by a healthcare professional.
Side Effects: Common side effects of entacapone include diarrhea, nausea, abdominal pain, dyskinesias, dizziness, and orthostatic hypotension (a drop in blood pressure upon standing). These side effects are usually mild to moderate in severity and often resolve with continued use or dose adjustment. However, in rare cases, entacapone may cause more serious side effects such as hepatotoxicity (liver damage) or neuroleptic malignant syndrome (a potentially life-threatening condition characterized by fever, altered mental status, and muscle rigidity).
Drug Interactions: Entacapone may interact with other medications, particularly those that are metabolized by the same liver enzymes or that affect dopamine levels in the brain. It is important for healthcare providers to review the patient's complete medication regimen to identify and manage potential drug interactions.
Monitoring: Patients taking entacapone should be monitored regularly for both therapeutic efficacy and potential adverse effects. This may involve assessments of motor function, gastrointestinal symptoms, liver function tests, and other relevant parameters.
Rank | Probiotic | Impact |
---|---|---|
genus | Bacillus | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Blautia hansenii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
species | Parabacteroides distasonis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Flavonifractor | genus | Decreases |
0 | 1 | Pseudobutyrivibrio | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Wansuia | genus | Decreases |
0 | 1 | Wujia | genus | Decreases |
0 | 1 | Butyrivibrio | genus | Decreases |
0 | 1 | Subdoligranulum | genus | Decreases |
0 | 1 | Komagataeibacter | genus | Decreases |
0 | 1 | Olsenella | genus | Decreases |
0 | 1 | Simiaoa | genus | Decreases |
0 | 1 | Intestinibaculum | genus | Decreases |
0 | 1 | Catenibacterium | genus | Decreases |
0 | 1 | Faecalitalea | genus | Decreases |
0 | 1 | Ligilactobacillus | genus | Decreases |
0 | 1 | Anaerostipes | genus | Decreases |
0 | 1 | Christensenella | genus | Decreases |
0 | 1 | Massilistercora | genus | Decreases |
0 | 1 | Faecalibacillus | genus | Decreases |
0 | 1 | Eubacterium | genus | Decreases |
0 | 1 | Qiania | genus | Decreases |
0 | 1 | Treponema | genus | Decreases |
0 | 1 | Lachnoanaerobaculum | genus | Decreases |
0 | 1 | Novisyntrophococcus | genus | Decreases |
0 | 1 | Maliibacterium | genus | Decreases |
0 | 1 | Adlercreutzia | genus | Decreases |
0 | 1 | Lactococcus | genus | Decreases |
0 | 1 | Coprobacter | genus | Decreases |
0 | 1 | Fannyhessea | genus | Decreases |
0 | 1 | Marvinbryantia | genus | Decreases |
0 | 1 | Bacillus | genus | Decreases |
0 | 1 | Lachnoclostridium | genus | Decreases |
0 | 1 | Faecalibaculum | genus | Decreases |
0 | 1 | Monoglobus | genus | Decreases |
0 | 1 | Faecalibacterium | genus | Decreases |
0 | 1 | Prevotella | genus | Decreases |
0 | 1 | Longicatena | genus | Decreases |
0 | 1 | Vescimonas | genus | Decreases |
0 | 1 | Mageeibacillus | genus | Decreases |
0 | 1 | Oscillibacter | genus | Decreases |
0 | 1 | Leyella | genus | Decreases |
0 | 1 | Phoenicibacter | genus | Decreases |
0 | 1 | Leuconostoc | genus | Decreases |
0 | 1 | Parvimonas | genus | Decreases |
0 | 1 | Allocoprobacillus | genus | Decreases |
0 | 1 | Butyricicoccus | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Bacteroides sp. A1C1 | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Flavonifractor plautii | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Bacteroides sp. HF-162 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Enterocloster clostridioformis | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Hungatella hathewayi | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Alistipes dispar | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Alistipes finegoldii | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Blautia pseudococcoides | species | Decreases |
0 | 1 | Lawsonibacter asaccharolyticus | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Bacteroides ovatus | species | Decreases |
0 | 1 | [Clostridium] scindens | species | Decreases |
0 | 1 | Paraprevotella clara | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Prevotella bivia | species | Decreases |
0 | 1 | Streptococcus sanguinis | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Pusillibacter faecalis | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Romboutsia sp. 13368 | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Streptococcus mutans | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Alistipes indistinctus | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Alistipes senegalensis | species | Decreases |
0 | 1 | Alistipes onderdonkii | species | Decreases |
0 | 1 | Alistipes shahii | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
0 | 1 | Prevotella dentalis | species | Decreases |
0 | 1 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 1.1 | 1.1 | |
Acne | 0.1 | -0.1 | |
ADHD | 3.3 | 1.2 | 1.75 |
Age-Related Macular Degeneration and Glaucoma | 1.2 | 0.1 | 11 |
Allergic Rhinitis (Hay Fever) | 2.8 | 0.4 | 6 |
Allergies | 5.7 | 3.5 | 0.63 |
Allergy to milk products | 2.7 | 0.6 | 3.5 |
Alopecia (Hair Loss) | 2 | 0.1 | 19 |
Alzheimer's disease | 7.4 | 8.7 | -0.18 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.9 | 0.7 | 3.14 |
Ankylosing spondylitis | 3.6 | 2.7 | 0.33 |
Anorexia Nervosa | 1.5 | 4.5 | -2 |
Antiphospholipid syndrome (APS) | 1.2 | 0.3 | 3 |
Asthma | 4.6 | 1.4 | 2.29 |
Atherosclerosis | 3 | 2.3 | 0.3 |
Atrial fibrillation | 4.2 | 2.5 | 0.68 |
Autism | 10.9 | 9.2 | 0.18 |
Autoimmune Disease | 0.1 | 1 | -9 |
Barrett esophagus cancer | 0.5 | 0.5 | |
benign prostatic hyperplasia | 0.4 | -0.4 | |
Biofilm | 1.4 | 1.4 | |
Bipolar Disorder | 2.4 | 1.7 | 0.41 |
Brain Trauma | 0.8 | 1.8 | -1.25 |
Breast Cancer | 0.7 | 0.7 | |
Cancer (General) | 1 | 1.2 | -0.2 |
Carcinoma | 5.3 | 3.5 | 0.51 |
Celiac Disease | 2.7 | 3.7 | -0.37 |
Cerebral Palsy | 0.9 | 2.2 | -1.44 |
Chronic Fatigue Syndrome | 6 | 7.5 | -0.25 |
Chronic Kidney Disease | 4.3 | 4.3 | 0 |
Chronic Lyme | 0.6 | 0.8 | -0.33 |
Chronic Obstructive Pulmonary Disease (COPD) | 1.4 | 2.5 | -0.79 |
Chronic Urticaria (Hives) | 0.4 | 1.3 | -2.25 |
Coagulation / Micro clot triggering bacteria | 0.3 | 2.3 | -6.67 |
Cognitive Function | 2.4 | 1.8 | 0.33 |
Colorectal Cancer | 6.8 | 3.3 | 1.06 |
Constipation | 1.9 | 1.2 | 0.58 |
Coronary artery disease | 2.8 | 4.3 | -0.54 |
COVID-19 | 8.3 | 14.5 | -0.75 |
Crohn's Disease | 9.9 | 8.7 | 0.14 |
Cushing's Syndrome (hypercortisolism) | 0.9 | -0.9 | |
cystic fibrosis | 1.4 | -1.4 | |
d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
deep vein thrombosis | 1.9 | 2.1 | -0.11 |
Denture Wearers Oral Shifts | 0.8 | 0.8 | |
Depression | 10.2 | 9 | 0.13 |
Dermatomyositis | 0.1 | 0.1 | |
Eczema | 1.7 | 0.9 | 0.89 |
Endometriosis | 2.6 | 2.4 | 0.08 |
Eosinophilic Esophagitis | 0.6 | 0.1 | 5 |
Epilepsy | 3.7 | 1.4 | 1.64 |
erectile dysfunction | 1.4 | 0.1 | 13 |
Fibromyalgia | 3.1 | 3 | 0.03 |
Functional constipation / chronic idiopathic constipation | 5.2 | 5.6 | -0.08 |
gallstone disease (gsd) | 3.3 | 1.2 | 1.75 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 2.5 | 1.9 | 0.32 |
Generalized anxiety disorder | 2.7 | 1.4 | 0.93 |
giant cell arteritis | 0.4 | -0.4 | |
Glioblastoma | 0.1 | 0.4 | -3 |
Gout | 1.9 | 1 | 0.9 |
Graves' disease | 1.5 | 3.2 | -1.13 |
Gulf War Syndrome | 1.4 | 1 | 0.4 |
Halitosis | 1.9 | 1.9 | |
Hashimoto's thyroiditis | 4.4 | 2.3 | 0.91 |
Heart Failure | 5.2 | 3.2 | 0.63 |
hemorrhagic stroke | 1.2 | 1.2 | |
Hidradenitis Suppurativa | 1.8 | 1.8 | |
High Histamine/low DAO | 1.5 | 0.6 | 1.5 |
hypercholesterolemia (High Cholesterol) | 0.9 | 0.2 | 3.5 |
hyperglycemia | 0.2 | 1 | -4 |
Hyperlipidemia (High Blood Fats) | 1.1 | 0.7 | 0.57 |
hypersomnia | 0.3 | 1.4 | -3.67 |
hypertension (High Blood Pressure | 4.7 | 6.2 | -0.32 |
Hypothyroidism | 0.5 | 1.6 | -2.2 |
Hypoxia | 2.1 | 0.1 | 20 |
IgA nephropathy (IgAN) | 1.7 | 4.8 | -1.82 |
Inflammatory Bowel Disease | 6.9 | 10.8 | -0.57 |
Insomnia | 2.4 | 3.5 | -0.46 |
Intelligence | 1.8 | 1.2 | 0.5 |
Intracranial aneurysms | 2 | 1.4 | 0.43 |
Irritable Bowel Syndrome | 7 | 5.8 | 0.21 |
ischemic stroke | 1.5 | 1.7 | -0.13 |
Juvenile idiopathic arthritis | 0.1 | 0.1 | 0 |
Liver Cirrhosis | 6.8 | 4.8 | 0.42 |
Long COVID | 8.5 | 10.7 | -0.26 |
Low bone mineral density | 0.1 | 2 | -19 |
Lung Cancer | 0.6 | 1.9 | -2.17 |
Lymphoma | 0.1 | -0.1 | |
Mast Cell Issues / mastitis | 0.6 | 1.1 | -0.83 |
ME/CFS with IBS | 1.1 | 3.1 | -1.82 |
ME/CFS without IBS | 1.3 | 1.8 | -0.38 |
membranous nephropathy | 0.1 | 0.1 | |
Menopause | 0.4 | 0.7 | -0.75 |
Metabolic Syndrome | 9.4 | 8.3 | 0.13 |
Mood Disorders | 9.8 | 7.1 | 0.38 |
multiple chemical sensitivity [MCS] | 0.6 | -0.6 | |
Multiple Sclerosis | 5.3 | 7.4 | -0.4 |
Multiple system atrophy (MSA) | 0.3 | 1 | -2.33 |
myasthenia gravis | 0.2 | 1.1 | -4.5 |
neuropathic pain | 2.2 | -2.2 | |
Neuropathy (all types) | 0.6 | 1.3 | -1.17 |
neuropsychiatric disorders (PANDAS, PANS) | 0.4 | 0.1 | 3 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 6.1 | 5.6 | 0.09 |
NonCeliac Gluten Sensitivity | 1.3 | 0.4 | 2.25 |
Obesity | 12.1 | 9.1 | 0.33 |
obsessive-compulsive disorder | 5.1 | 5 | 0.02 |
Osteoarthritis | 3.2 | 1.4 | 1.29 |
Osteoporosis | 1.8 | 1.9 | -0.06 |
pancreatic cancer | 1 | 1 | |
Parkinson's Disease | 8.4 | 9.3 | -0.11 |
Polycystic ovary syndrome | 6.9 | 3.6 | 0.92 |
Postural orthostatic tachycardia syndrome | 0.5 | 0.6 | -0.2 |
Premenstrual dysphoric disorder | 1 | 0.2 | 4 |
primary biliary cholangitis | 0.7 | 2.1 | -2 |
Primary sclerosing cholangitis | 1.4 | 4.1 | -1.93 |
Psoriasis | 3.2 | 3.1 | 0.03 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 9 | 6 | 0.5 |
Rosacea | 1.3 | 1 | 0.3 |
Schizophrenia | 6.6 | 4 | 0.65 |
scoliosis | 0.8 | 1.5 | -0.88 |
sensorineural hearing loss | 0.4 | 0.4 | |
Sjögren syndrome | 2.1 | 2.9 | -0.38 |
Sleep Apnea | 2.9 | 2.1 | 0.38 |
Slow gastric motility / Gastroparesis | 1.1 | 0.2 | 4.5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 2.1 | 2.1 | |
Stress / posttraumatic stress disorder | 2.5 | 2.2 | 0.14 |
Systemic Lupus Erythematosus | 4.5 | 3.5 | 0.29 |
Tic Disorder | 1.7 | 2.3 | -0.35 |
Tourette syndrome | 0.5 | 0.3 | 0.67 |
Type 1 Diabetes | 4.1 | 3.5 | 0.17 |
Type 2 Diabetes | 10.7 | 7.4 | 0.45 |
Ulcerative colitis | 6.4 | 8.3 | -0.3 |
Unhealthy Ageing | 6.3 | 2.7 | 1.33 |
Vitiligo | 2 | 1.2 | 0.67 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]